EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Costunolide Inhibits Chronic Kidney Disease Development by Attenuating IKKβ/NF-κB Pathway

Yang Zhao iD, Yi-Han Wang, Wei-Chao Tu, Da-Wei Wang, Mu-Jun Lu, Yuan Shao

Drug Design, Development and Therapy · 2024-07 · Volume 18 · 2693-2712

DOI: 10.2147/dddt.s466092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024-07. Verfasst von Yang Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, 201800, People's Republic of China. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Sesquiterpenes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicSesquiterpenesAnimalsHumansMaleMiceDisease Models, AnimalDose-Response Relationship, DrugFibrosisI-kappa B KinaseInflammationMice, Inbred C57BLNF-kappa BSignal TransductionUreteral ObstructionLactones

Stichwörter der Autor:innen

IKKβ/NF-κB pathwaychronic kidney diseasecostunoliderenal fibrosis

Substanzen

I-kappa B KinaseNF-kappa BSesquiterpenescostunolideLactonesIkbkb protein, mouse

Autor:innen und Institutionen

  • Department of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, 201800, People's Republic of China.
  • Department of Urology, Sixth People's Hospital South Campus Affiliated to Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Department of Urology and Andrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Shanghai Institute of Andrology, Shanghai, People's Republic of China.

ORCID-Profile: Yang Zhao

Zitieren

APA

Zhao, Y., Wang, Y. H., Tu, W. C., Wang, D. W., Lu, M. J., & Shao, Y. (2024). Costunolide Inhibits Chronic Kidney Disease Development by Attenuating IKKβ/NF-κB Pathway. Drug Design, Development and Therapy, Volume 18, 2693-2712. https://doi.org/10.2147/dddt.s466092

Vancouver

Zhao Y, Wang YH, Tu WC, Wang DW, Lu MJ, Shao Y. Costunolide Inhibits Chronic Kidney Disease Development by Attenuating IKKβ/NF-κB Pathway. Drug Design, Development and Therapy. 2024;Volume 18:2693-2712. doi:10.2147/dddt.s466092

BibTeX
@article{Zhao2024,
  author = {Zhao, Yang and Wang, Yi-Han and Tu, Wei-Chao and Wang, Da-Wei and Lu, Mu-Jun and Shao, Yuan},
  title = {Costunolide Inhibits Chronic Kidney Disease Development by Attenuating IKKβ/NF-κB Pathway},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  volume = {Volume 18},
  pages = {2693--2712},
  doi = {10.2147/dddt.s466092}
}
Kostenlos starten →